Christina D Williams1,2, Alyssa Jasmine Bullard3, Meghan O'Leary3, Reana Thomas3, Thomas S Redding3, Karen Goldstein4,5. 1. Cooperative Studies Program Epidemiology Center-Durham, Durham Veterans Affairs Health Care System, 508 Fulton Street, Durham, NC, 27705, USA. Christina.williams4@va.gov. 2. Department of Medicine, Division of Medical Oncology, Duke University, Durham, NC, USA. Christina.williams4@va.gov. 3. Cooperative Studies Program Epidemiology Center-Durham, Durham Veterans Affairs Health Care System, 508 Fulton Street, Durham, NC, 27705, USA. 4. Center for Health Services Research in Primary Care, Durham Veterans Affairs Health Care System, 508 Fulton Street, Durham, NC, 27705, USA. 5. Department of Medicine, Division of General Internal Medicine, Duke University Medical Center, 411 West Chapel Hill Street, Suite 500, Durham, NC, 27701, USA.
Abstract
BACKGROUND/ OBJECTIVE: Despite increases in BRCA mutation testing, racial/ethnic disparities in counseling and testing have persisted for decades. The purpose of the review was to summarize recent literature as it relates to detecting, understanding, and reducing disparities in BRCA counseling and testing. DESIGN: This is a narrative review of articles published January 2012 to July 2017 relevant to genetic testing and counseling, breast and ovarian cancer, and minority health and heath disparities. Twenty-three articles were included in this review. RESULTS: Studies report lower counseling and/or testing rates for eligible racial/ethnic minorities among family members of high-risk individuals as well as among breast cancer survivors. Key barriers and facilitators of disparate BRCA counseling/testing that emerged in this review included awareness, cost-related factors, stress and distrust, family concerns and communication, and provider communication and referral. To address differential access to and use of BRCA testing services and expand testing in minority populations, it is necessary for interventions to focus on improving awareness, risk-perception, and family and patient-provider communication. CONCLUSION: Multi-level and targeted interventions are needed to reduce persistent racial/ethnic disparities and improve assessment, provider recommendations, counseling and testing among minority populations.
BACKGROUND/ OBJECTIVE: Despite increases in BRCA mutation testing, racial/ethnic disparities in counseling and testing have persisted for decades. The purpose of the review was to summarize recent literature as it relates to detecting, understanding, and reducing disparities in BRCA counseling and testing. DESIGN: This is a narrative review of articles published January 2012 to July 2017 relevant to genetic testing and counseling, breast and ovarian cancer, and minority health and heath disparities. Twenty-three articles were included in this review. RESULTS: Studies report lower counseling and/or testing rates for eligible racial/ethnic minorities among family members of high-risk individuals as well as among breast cancer survivors. Key barriers and facilitators of disparate BRCA counseling/testing that emerged in this review included awareness, cost-related factors, stress and distrust, family concerns and communication, and provider communication and referral. To address differential access to and use of BRCA testing services and expand testing in minority populations, it is necessary for interventions to focus on improving awareness, risk-perception, and family and patient-provider communication. CONCLUSION: Multi-level and targeted interventions are needed to reduce persistent racial/ethnic disparities and improve assessment, provider recommendations, counseling and testing among minority populations.
Entities:
Keywords:
Breast cancer; Genetic counseling; Genetic testing; Health care disparities; Hereditary cancer syndrome
Authors: Mary B Daly; Robert Pilarski; Michael Berry; Saundra S Buys; Meagan Farmer; Susan Friedman; Judy E Garber; Noah D Kauff; Seema Khan; Catherine Klein; Wendy Kohlmann; Allison Kurian; Jennifer K Litton; Lisa Madlensky; Sofia D Merajver; Kenneth Offit; Tuya Pal; Gwen Reiser; Kristen Mahoney Shannon; Elizabeth Swisher; Shaveta Vinayak; Nicoleta C Voian; Jeffrey N Weitzel; Myra J Wick; Georgia L Wiesner; Mary Dwyer; Susan Darlow Journal: J Natl Compr Canc Netw Date: 2017-01 Impact factor: 11.908
Authors: Danielle S Chun; Brygida Berse; Vickie L Venne; Scott L DuVall; Kelly K Filipski; Michael J Kelley; Laurence J Meyer; Michael S Icardi; Julie A Lynch Journal: Fam Cancer Date: 2017-01 Impact factor: 2.375
Authors: Aryana S Jacobs; Marc D Schwartz; Heiddis Valdimarsdottir; Rachel H Nusbaum; Gillian W Hooker; Tiffani A DeMarco; Jessica E Heinzmann; Wendy McKinnon; Shelley R McCormick; Claire Davis; Andrea D Forman; Alexandra Perez Lebensohn; Emily Dalton; Diana Moglia Tully; Kristi D Graves; Morgan Similuk; Scott Kelly; Beth N Peshkin Journal: Fam Cancer Date: 2016-10 Impact factor: 2.375
Authors: Deborah J Macdonald; Julia Deri; Charité Ricker; Martin A Perez; Raquel Ogaz; Nancy Feldman; Lori A Viveros; Benjamin Paz; Jeffrey N Weitzel; Kathleen R Blazer Journal: Fam Cancer Date: 2012-09 Impact factor: 2.375
Authors: Katrina Armstrong; Barbara Weber; Jill Stopfer; Kathleen Calzone; Mary Putt; James Coyne; J Sanford Schwartz Journal: Am J Med Genet A Date: 2003-03-01 Impact factor: 2.802
Authors: Morgan Butrick; Scott Kelly; Beth N Peshkin; George Luta; Rachel Nusbaum; Gillian W Hooker; Kristi Graves; Lisa Feeley; Claudine Isaacs; Heiddis B Valdimarsdottir; Lina Jandorf; Tiffani DeMarco; Marie Wood; Wendy McKinnon; Judy Garber; Shelley R McCormick; Marc D Schwartz Journal: Genet Med Date: 2014-09-18 Impact factor: 8.822
Authors: Cecelia A Bellcross; Lucy A Peipins; Frances A McCarty; Juan L Rodriguez; Nikki A Hawkins; Sharon Hensley Alford; Steven Leadbetter Journal: Genet Med Date: 2014-06-19 Impact factor: 8.822
Authors: Sarah M Lima; Meaghan Nazareth; Karen M Schmitt; Andria Reyes; Elaine Fleck; Gary K Schwartz; Mary Beth Terry; Grace C Hillyer Journal: J Community Genet Date: 2022-10-13
Authors: Alejandra Hurtado-de-Mendoza; Valerie F Reyna; Christopher R Wolfe; Sara Gómez-Trillos; Arnethea L Sutton; Ashleigh Brennan; Vanessa B Sheppard Journal: Prev Med Rep Date: 2022-07-05
Authors: Megan C Roberts; June Mullaney Mader; Erin Turbitt; Amelia K Smit; Latrice Landry; Dana Lee Olstad; Lauren E Passero; Caitlin G Allen Journal: Front Genet Date: 2022-06-09 Impact factor: 4.772
Authors: Eryn F Braley; Angela C Bedard; Sophie Sun; Kasmintan A Schrader; Jennifer Nuk; Quan Hong; James E J Bedard Journal: Fam Cancer Date: 2021-07-07 Impact factor: 2.446
Authors: Noura S Abul-Husn; Emily R Soper; Jacqueline A Odgis; Sinead Cullina; Dean Bobo; Arden Moscati; Jessica E Rodriguez; Ruth J F Loos; Judy H Cho; Gillian M Belbin; Sabrina A Suckiel; Eimear E Kenny Journal: Genome Med Date: 2019-12-31 Impact factor: 11.117